Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Actavis Q3 Earnings Preview: Solid Results Expected On The Back Of Recent Acquisitions
Bidness Etc.
Monday, November 3, 2014 - 8:43am
tags:
Actavis, earnings
Arena Pharmaceuticals beats 3Q net income expectations, misses revenue forecasts
Yahoo/AP
Monday, November 3, 2014 - 8:16am
tags:
Arena Pharmaceuticals, earnings
Threshold Pharmaceuticals posts 3Q loss, results miss Wall Street forecasts
Yahoo/AP
Monday, November 3, 2014 - 8:07am
tags:
earnings, Threshold Pharmaceuticals
How Merck Found Its Way Into Millions Of Medicine Cabinets
Investopedia.com
Monday, November 3, 2014 - 8:06am
tags:
Merck
Nymox Drug for Enlarged Prostate Doesn’t Meet Targets
Bloomberg
Monday, November 3, 2014 - 8:04am
tags:
Nymox, enlarged prostate, NX-1207
Intra-Cellular posts 3Q loss
Yahoo/AP
Monday, November 3, 2014 - 8:01am
tags:
Intra-Cellular Therapies, earnings
Billionaire Carl Berg developing prostate cancer test
San Francisco Chronicle,
Sunday, November 2, 2014 - 9:29am
tags:
prostate cancer, diagnostics, Carl Berg, Berg LLC
Doctors refusing to prescribe statins (in the UK)
The Telegraph, UK
Saturday, November 1, 2014 - 3:15pm
tags:
statins
China launches erectile dysfunction drug less than half the price of Viagra
India.com, India
Saturday, November 1, 2014 - 1:45pm
tags:
China, Pfizer, Viagra, generics, erectile dysfunction
Bayer Reports Strong Q3 Results, Remains Attractive
Seeking Alpha
Saturday, November 1, 2014 - 1:43pm
tags:
Bayer, earnings
Shasun Chemicals develops new drug for shrinking tumours
PharmaBiz
Saturday, November 1, 2014 - 1:33pm
tags:
Shasun Pharma
Saskatchewan to fund treatment with AUBAGIO® for Relapsing Remitting Multiple Sclerosis
Yahoo/CNW Group
Saturday, November 1, 2014 - 12:52pm
tags:
Aubagio, multiple sclerosis, MS, Sanofi
Investors Could Triple Their Investments in AbbVie
Yahoo/Guru Focus
Saturday, November 1, 2014 - 12:48pm
tags:
AbbVie
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y
Yahoo/Zacks
Saturday, November 1, 2014 - 12:46pm
tags:
Alkermes, earnings
Fundamentals, Technicals Still Intact At Gilead Sciences
Investor's.com
Saturday, November 1, 2014 - 12:45pm
tags:
Gilead Sciences
Gilead Sciences: Harvoni Still Selling Like Hotcakes
Barron's
Friday, October 31, 2014 - 2:14pm
tags:
Gilead Sciences, hepatitis C, Harvoni
A ‘Strange Back and Forth’ Between Sarepta and the FDA
WSJ Pharmalot
Friday, October 31, 2014 - 2:13pm
tags:
Sarepta Therapeutics, FDA, eteplirsen, Duchenne Muscular Dystrophy
AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal
WSJ Online
Friday, October 31, 2014 - 2:02pm
tags:
AbbVie, M&A, Rick Gonzalez
FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Friday, October 31, 2014 - 2:01pm
tags:
FDA, Daiichi Sankyo, advisory panels, bloodthinners, Savaysa, edoxaban
Lawmaker Plans a Bill to Force Pharma to Disclose Compassionate Use Info
WSJ Pharmalot
Friday, October 31, 2014 - 9:58am
tags:
compassionate use guidelines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.